ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
Radford JA, Rohatiner AZ, Ryder WD, Deakin DP, Barbui T, Lucie NP, Rossi A, Dunlop DJ, Cowan RA, Wilkinson PM, Gupta RK, James RD, Shamash J, Chang J, Crowther D, Lister TA.
Radford JA, et al. Among authors: deakin dp.
J Clin Oncol. 2002 Jul 1;20(13):2988-94. doi: 10.1200/JCO.2002.11.107.
J Clin Oncol. 2002.
PMID: 12089229
Clinical Trial.